References
Harris AC, Kitko CL, Couriel DR, Braun TM, Choi SW, Magenau J, Mineishi S, Pawarode A, Yanik G, Levine JE (2013) Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Haematologica 98(2):179–184. https://doi.org/10.3324/haematol.2012.073189
Shem-Tov N, Saraceni F, Danylesko I, Shouval R, Yerushalmi R, Nagler A, Shimoni A (2017) Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse. Biol Blood Marrow Transplant 23(7):1087–1094. https://doi.org/10.1016/j.bbmt.2017.03.023
DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á et al (2020) Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383(7):617–629. https://doi.org/10.1056/NEJMoa2012971
Gunes G, Goker H, Demiroglu H, Malkan UY, Buyukasik Y (2019) Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors. Bone Marrow Transplant 54(4):595–600. https://doi.org/10.1038/s41409-018-0303-5
Yuda S, Fuji S, Onishi A, Tanaka T, Inamoto Y, Kurosawa S, Kim SW, Fukuda T (2019) Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 25(6):1152–1157. https://doi.org/10.1016/j.bbmt.2019.01.011
Acknowledgements
We would like to thank Editage (http://www.editage.cn) for English language editing.
Funding
This work was supported by NINGBO Medical & Health Leading Academic Discipline Project (Project Number 2022-S05).
Author information
Authors and Affiliations
Contributions
YL managed the patient and performed the research. QQL reviewed patient’s clinical and laboratory data and wrote the first draft of the manuscript. All authors participated and commented on the previous versions of the manuscript and approved its final.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the editorial office of this journal.
Conflicts of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lin, Q., Ye, P., Wang, T. et al. Successful use of venetoclax combined with azacitidine in isolated extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report. Ann Hematol 103, 335–337 (2024). https://doi.org/10.1007/s00277-023-05401-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05401-4